Fady Ibraham Malik - Jan 21, 2025 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Signature
/s/ John O. Faurescu, attorney-in-fact for Dr. Malik
Stock symbol
CYTK
Transactions as of
Jan 21, 2025
Transactions value $
-$70,640
Form type
4
Date filed
1/21/2025, 04:29 PM
Previous filing
Jan 10, 2025
Next filing
Feb 4, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $21.2K +2K +1.72% $10.60 118K Jan 21, 2025 Direct
transaction CYTK Common Stock Sale -$91.8K -2K -1.69% $45.92 116K Jan 21, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -2K -5.11% $0.00 37.1K Jan 21, 2025 Common Stock 2K $10.60 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).